期刊文献+

年龄相关性黄斑变性的病因研究 被引量:4

Recent advance of the study on age-related macular degeneration
下载PDF
导出
摘要 年龄相关性黄斑变性(age-related macular degeneration,AMD)是发达国家老年人致盲的主要原因,在我国其发病率也呈上升趋势。它是一种由环境和遗传共同作用所导致的复杂性疾病。患病率随年龄的增加而增加。吸烟是明确的危险因素。应用基因组连锁扫描和关联分析,已经发现多个潜在的致病基因。补体因子H与AMD的关系提示替代补体途径在AMD发生发展过程中的重要作用。PLEKHA1/LOC387715/HTRA1基因位点的变异也是AMD发病的主要危险因素。理解环境和遗传因素之间的交互作用将有利于AMD预防措施和治疗手段的探索。本文对目前AMD的流行病学,发病机制和病因学的进展进行综述。 Age-related macular degeneration (AMD) is the leading cause of blindness in industrialized countries and the incidence is rising in China. caused by the combination AMD is a complex disease of environmental factors and genetic predisposition. The prevalence of AMD increases with age. The adverse effect of smoking is well established. Using genome linkage scan and association studies, multiple potentially causative genes have been identified. The association of complement factor H with AMD highlights the importance of the alternative complement pathway in the development of AMD. Variants in the gene for PLEKHA1/LOC387715/HTRA1 have been implicated as a major risk for the development of AMD. Understanding the causative environmental and genetic interactions will facilitate the development of future preventive methods and treatments. We reviewed the urrent studies of epidemiology, pathogenesis and etiology of AMD.
作者 李娟 胡永华
出处 《国际眼科杂志》 CAS 2008年第10期2102-2105,共4页 International Eye Science
基金 中国"十一五"国家科技支撑计划"老年相关疾病的干预控制研究"重点项目(No.2006BAI02B05)~~
关键词 年龄相关性黄斑变性 发病机制 遗传易感性 危险因素 age-related macular degeneration pathogenesis genetic predisposition environmental risk
  • 相关文献

参考文献2

二级参考文献8

共引文献38

同被引文献26

  • 1汤如.老年性黄斑变性病人焦虑心理分析[J].护理研究,2004,18(8):1325-1326. 被引量:5
  • 2徐海峰,董晓光,王伟,陈焓.玻璃体内注射曲安奈德治疗黄斑水肿[J].中华眼底病杂志,2005,21(4):205-208. 被引量:59
  • 3李文博,陈松.老年性黄斑变性发病机制的研究进展[J].中华眼底病杂志,2006,22(4):283-285. 被引量:26
  • 4夏伟丹,刘晓玲,李英姿.玻璃体腔内注射的护理配合[J].现代中西医结合杂志,2007,16(3):403-403. 被引量:8
  • 5CHUNG SE,KANG SW,LEE JH,KIM YT. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-relat- ed macular degeneration[J]. Ophthalmology,2011,118(5):840-845.
  • 6KIM SW, OH J, KWON SS, YOO J,HUH K. Comparison of choroidal thickness among patients with healthy eyes,early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy,and polypoi- dal choroidal vasculopathy[J]. Retina,2011, 31(9):1904-1911.
  • 7YAMAZAKI T,KOIZUMI H, YAMAGISHI T, KINOSHITA S. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration;12-month re- sults[J]. Ophtkalmology,2012,119(8):1621-1627.
  • 8SUZUMA TE, UEKI H,MAEKAWA Y, KITAOKA T. Enhanced depth imaging optical coherence tomography of the choroid in central retinal vein occlusion[J]. Am J Ophthalmol,2013,156(3):543-547.
  • 9LAINS I,FIGUEIRA J,SANTOS AR,BALTAR A1COSTA M, NUNES S,et al. Choroidal thickness in diabetic retinopathy: the influence of antiangiogenic therapy[J]. Retina,2014,34(6):1199-1207.
  • 10MARUKO I, HDA T, OYAMADA H, SUGANO Y, OJIMA A, SEK3RYU T. Choroidal thickness changes after intravitxeal ranibizumab and photodynamic therapy in recurrent polypoi- dal choroidal vasculopathy[J]. Am J OphtMmol, 2013,156(3):548-556.

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部